Gene Techno Science Co., Ltd., one of the Hokkaido VC's portfolio companies, announced a licensing agreement with Kaken Pharmaceutical Co., Ltd. Hokkaido VC is the lead investor and Ikkei Matsuda, president of Hokkaido VC, is serving as a director of Gene Techno Science Co., Ltd.

Link to the press release from Gene Techno Science Co., Ltd. is here(a PDF file, 8KB).
Link to the press release from Kaken Pharmaceutical Co., Ltd. is here.